Total Payments
$10,219
2024 Payments
$6,101
Companies
33
Transactions
400
Medicare Patients
649
Medicare Billing
$77,542
Payment Breakdown by Category
Food & Beverage$6,515 (63.8%)
Other$2,178 (21.3%)
Consulting$1,215 (11.9%)
Education$311.74 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,515 | 391 | 63.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,178 | 4 | 21.3% |
| Consulting Fee | $1,215 | 1 | 11.9% |
| Education | $311.74 | 4 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TG Therapeutics, Inc. | $3,865 | 19 | $0 (2024) |
| Biogen, Inc. | $1,098 | 77 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,009 | 82 | $0 (2024) |
| EMD Serono, Inc. | $654.03 | 36 | $0 (2024) |
| GENZYME CORPORATION | $602.74 | 23 | $0 (2024) |
| Celgene Corporation | $521.14 | 38 | $0 (2024) |
| ABBVIE INC. | $482.57 | 27 | $0 (2024) |
| Lilly USA, LLC | $338.90 | 20 | $0 (2024) |
| BANNER LIFE SCIENCES, LLC | $297.70 | 7 | $0 (2024) |
| Genentech USA, Inc. | $212.82 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,101 | 144 | TG Therapeutics, Inc. ($3,774) |
| 2023 | $2,201 | 140 | Biogen, Inc. ($422.79) |
| 2022 | $1,333 | 86 | Biogen, Inc. ($337.76) |
| 2021 | $583.73 | 30 | Novartis Pharmaceuticals Corporation ($101.52) |
All Payment Transactions
400 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $7.04 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/10/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $23.10 | General |
| 12/05/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: Neurology | ||||||
| 11/27/2024 | GENZYME CORPORATION | AUBAGIO (Drug) | Education | In-kind items and services | $66.00 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.20 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $9.21 | General |
| 11/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.23 | General |
| 11/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $2.61 | General |
| 11/20/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.89 | General |
| 11/19/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Immunology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Immunology | ||||||
| 11/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.49 | General |
| 11/06/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $26.14 | General |
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 316 | 620 | $128,112 | $31,021 |
| 2020 | 6 | 333 | 865 | $168,957 | $46,522 |
Total Patients
649
Total Services
1,485
Medicare Billing
$77,542
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 103 | 240 | $60,000 | $13,901 | 23.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 210 | $35,948 | $10,104 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 99 | $23,134 | $4,460 | 19.3% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2021 | 21 | 39 | $7,260 | $1,953 | 26.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 11 | 14 | $1,554 | $524.05 | 33.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 12 | 18 | $216.00 | $78.43 | 36.3% |
| 80307 | Testing for presence of drug | Office | 2020 | 120 | 318 | $79,500 | $19,020 | 23.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 131 | 401 | $58,205 | $18,519 | 31.8% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2020 | 27 | 86 | $20,325 | $5,329 | 26.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $5,700 | $1,895 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 25 | $5,035 | $1,682 | 33.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 15 | 16 | $192.00 | $76.58 | 39.9% |
About Patricia Teeter, APRN
Patricia Teeter, APRN is a Family healthcare provider based in Wahoo, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2019. The National Provider Identifier (NPI) number assigned to this provider is 1477011294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patricia Teeter, APRN has received a total of $10,219 in payments from pharmaceutical and medical device companies, with $6,101 received in 2024. These payments were reported across 400 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,515).
As a Medicare-enrolled provider, Teeter has provided services to 649 Medicare beneficiaries, totaling 1,485 services with total Medicare billing of $77,542. Data is available for 2 years (2020–2021), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Wahoo, NE
- Active Since 03/11/2019
- Last Updated 12/06/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1477011294
Products in Payments
- BRIUMVI (Drug) $3,865
- KESIMPTA (Drug) $770.19
- TYSABRI (Biological) $579.38
- ZEPOSIA (Drug) $496.53
- VUMERITY (Drug) $483.14
- EMGALITY (Drug) $338.90
- AUBAGIO (Drug) $305.07
- BAFIERTAM (Drug) $297.70
- MAVENCLAD (Drug) $255.59
- MAYZENT (Drug) $238.69
- BOTOX (Biological) $208.90
- UBRELVY (Drug) $203.93
- Ocrevus (Biological) $180.26
- NURTEC ODT (Drug) $139.30
- Ponvory (Drug) $133.40
- ACTHAR (Biological) $116.90
- NUEDEXTA (Drug) $111.62
- Dysport (Drug) $108.20
- QULIPTA (Drug) $87.15
- VYEPTI (Biological) $71.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.